Search
Now showing items 1-1 of 1
Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry
(Clinical And Experimental Rheumatology S.A.S, 2019-08-14)
Objectives: To assess the real-life retention rate of certolizumab and factors related to retention of certolizumab.
Methods: We analysed all patients who received at least 1 dose of certolizumab and were registered in ...